Eosinophilic Esophagitis - Pipeline Review, H1 2014: Market Trends and Forecast Report

317 views

Published on

Eosinophilic Esophagitis - Pipeline Review, H1 2014 @ http://www.researchmoz.us/eosinophilic-esophagitis-pipeline-review-h1-2014-report.html

This report provides comprehensive information on the therapeutic development for Eosinophilic Esophagitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Published in: Healthcare, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
317
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Eosinophilic Esophagitis - Pipeline Review, H1 2014: Market Trends and Forecast Report

  1. 1. Eosinophilic Esophagitis - Pipeline Review, H1 2014 Eosinophilic Esophagitis - Pipeline Review, H1 2014 Summary Global Markets Directs, Eosinophilic Esophagitis - Pipeline Review, H1 2014, provides an overview of the Eosinophilic Esophagitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Eosinophilic Esophagitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Eosinophilic Esophagitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Eosinophilic Esophagitis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Eosinophilic Esophagitis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Eosinophilic Esophagitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Eosinophilic Esophagitis pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Eosinophilic Esophagitis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Eosinophilic Esophagitis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 global Markets Direct Report Coverage 6 eosinophilic Esophagitis Overview 7 therapeutics Development 8 pipeline Products For Eosinophilic Esophagitis - Overview 8 pipeline Products For Eosinophilic Esophagitis - Comparative Analysis 9 eosinophilic Esophagitis - Therapeutics Under Development By Companies 10 eosinophilic Esophagitis - Pipeline Products Glance 12 late Stage Products 12 clinical Stage Products 13 early Stage Products 14 Eosinophilic Esophagitis - Pipeline Review, H1 2014
  2. 2. unknown Stage Products 15 eosinophilic Esophagitis - Products Under Development By Companies 16 eosinophilic Esophagitis - Companies Involved In Therapeutics Development 17 novartis Ag 17 aptalis Pharma Inc. 18 teva Pharmaceutical Industries Limited 19 dbv Technologies 20 meritage Pharma, Inc. 21 oxagen Limited 22 dr. Falk Pharma Gmbh 23 receptos, Inc. 24 lipella Pharmaceuticals, Inc. 25 eosinophilic Esophagitis - Therapeutics Assessment 26 assessment By Monotherapy Products 26 assessment By Target 27 assessment By Mechanism Of Action 30 assessment By Route Of Administration 33 assessment By Molecule Type 35 drug Profiles 37 reslizumab - Drug Profile 37 product Description 37 mechanism Of Action 37 r&d Progress 37 oc-459 - Drug Profile 38 product Description 38 mechanism Of Action 38 r&d Progress 38 budesonide - Drug Profile 40 product Description 40 mechanism Of Action 40 r&d Progress 40 qax-576 - Drug Profile 41 product Description 41 mechanism Of Action 41 r&d Progress 41 rpc-4046 - Drug Profile 43 product Description 43 mechanism Of Action 43 r&d Progress 43 eur-1100 - Drug Profile 44 product Description 44 mechanism Of Action 44 r&d Progress 44 drug For Eosinophilic Esophagitis - Drug Profile 45 product Description 45 mechanism Of Action 45 r&d Progress 45 tacrolimus Liposomal - Drug Profile 46 product Description 46 mechanism Of Action 46 r&d Progress 46 budesonide - Drug Profile 47 product Description 47 mechanism Of Action 47 r&d Progress 47 eosinophilic Esophagitis - Recent Pipeline Updates 50 eosinophilic Esophagitis - Dormant Projects 54 eosinophilic Esophagitis - Product Development Milestones 55 featured News & Press Releases 55 aug 13, 2012: Meritage Initiates Clinical Trial Of Oral Budesonide Suspension For Adolescent And Adult Patients With Eosinophilic Esophagitis 55 may 10, 2011: Meritage Pharma Reports Positive Phase Iib Data For Oral Budesonide Suspension In Pediatric Patients With Eosinophilic Esophagitis 55 may 10, 2011: Meritage Reports Positive Phase Iib Data For Oral Budesonide Suspension In Pediatric Patients With Eosinophilic Esophagitis 56 nov 23, 2009: Ception Therapeutics And Cephalon Provide Initial Results Of A Phase Iib/iii Study Of Cinquil In Pediatric Eosinophilic Esophagitis 57 appendix 59 methodology 59 coverage 59 secondary Research 59 primary Research 59 Eosinophilic Esophagitis - Pipeline Review, H1 2014
  3. 3. expert Panel Validation 59 contact Us 60 disclaimer 60 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Eosinophilic Esophagitis - Pipeline Review, H1 2014

×